The activation of OR51E1 causes growth suppression of human prostate cancer cells

The development of prostate cancer (PCa) is regulated by the androgen-dependent activity of the androgen receptor (AR). Androgen-deprivation therapy (ADT) is therefore the gold standard treatment to suppress malignant progression of PCa. Nevertheless, due to the development of castration resistance,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Maßberg, Désirée, Jovancevic, Nikolina, Offermann, Anne, Simon, Annika, Baniahmad, Aria, Perner, Sven, Pungsrinont, Thanakorn, Luko, Katarina, Philippou, Stathis, Ubrig, Burkhard, Heiland, Markus, Weber, Lea, Altmüller, Janine, Becker, Christian, Gisselmann, Günter, Gelis, Lian, Hatt, Hanns
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2016
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5217014/
https://ncbi.nlm.nih.gov/pubmed/27374083
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.10197
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars